Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study.
Williams-Gray, Caroline H
Yarnall, Alison J
Boucher, John J
Lawson, Rachael A
Wijeyekoon, Ruwani S
Barker, Roger A
Burn, David J
Von Zglinicki, Thomas
MetadataShow full item record
JournalJournal of Parkinson's disease
AbstractBackground: Cognitive decline is a frequent complication of Parkinson's disease (PD) and the identification of predictive biomarkers for it would help in its management. Objective: Our aim was to analyse whether senescence markers (telomere length, p16 and p21) or their change over time could help to better predict cognitive and motor progression of newly diagnosed PD patients. We also compared these senescence markers to previously analysed markers of inflammation for the same purpose. Methods: This study examined the association of blood-derived markers of cell senescence and inflammation with motor and cognitive function over time in an incident PD cohort (the ICICLE-PD study). Participants (154 newly diagnosed PD patients and 99 controls) underwent physical and cognitive assessments over 36 months of follow up. Mean leukocyte telomere length and the expression of senescence markers p21 and p16 were measured at two time points (baseline and 18 months). Additionally, we selected five inflammatory markers from existing baseline data. Results: We found that PD patients had shorter telomeres at baseline and 18 months compared to age-matched healthy controls which also correlated to dementia at 36 months. Baseline p16 levels were associated with faster rates of motor and cognitive decline over 36 months in PD cases, while a simple inflammatory summary score at baseline best predicted cognitive score over this same time period in PD patients. Conclusion: Our study suggests that both inflammatory and senescence markers (p16) are valuable predictors of clinical progression in PD patients.
- Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.
- Authors: Stuart S, Lawson RA, Yarnall AJ, Nell J, Alcock L, Duncan GW, Khoo TK, Barker RA, Rochester L, Burn DJ, ICICLE-PD study group.
- Issue date: 2019 Nov
- Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
- Authors: Sleeman I, Lawson RA, Yarnall AJ, Duncan GW, Johnston F, Khoo TK, Burn DJ
- Issue date: 2019
- Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease.
- Authors: Jones JD, Rahmani E, Garcia E, Jacobs JP
- Issue date: 2020 Mar
- Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study.
- Authors: Zhang JR, Cao YL, Li K, Wang F, Wang YL, Wu JJ, Pei SF, Chen J, Mao CJ, Liu CF
- Issue date: 2021 Jan
- Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.
- Authors: Martin GP, McDonald KR, Allsop D, Diggle PJ, Leroi I
- Issue date: 2020 Jan